Effect of AXOS on the Colon Metabolism in Healthy Volunteers
NCT ID: NCT01656499
Last Updated: 2015-01-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
20 participants
INTERVENTIONAL
2011-03-31
2012-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study to Evaluate the Pharmacokinetics, Metabolism, and Excretion of AK0529
NCT03400995
Absorption, Metabolism, Excretion and Absolute Bioavailability
NCT03250039
A Study Assessing the Mass Balance, Pharmacokinetics, and Metabolite Profiles of a Single Oral Dose of [14C]-INCB086550
NCT05101369
Drug Metabolism, Excretion, and Human Body Composition of Aximus Capsules
NCT06307132
A Study Investigating [14C]-Labeled RO7269162 in Healthy Male Participants
NCT06733298
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Arabinoxylanoligosaccharides (AXOS)
AXOS (2 x 5g WBE/day)
Arabinoxylanoligosaccharides
Maltodextrine (placebo)
Maltodextrine (2 x 5g/day)
Maltodextrine
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Arabinoxylanoligosaccharides
Maltodextrine
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* regular dietary pattern (3 meals/day)
* age: 18-45y
* BMI: 18,5-27 kg/m2
Exclusion Criteria
* abdominal surgery in the past, with the exception of appendectomy
* intake of medication influencing the gastro-intestinal system 14 days prior to the study
* in treatment at a dietician
* serious liver- or kidney failure
* vegetarians
* intake of pre- and/or probiotics
* Exposure to radioactivity 1 year prior to the study
18 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
KU Leuven
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kristin Verbeke
Professor Kristin Verbeke, Ph. D.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UZ Leuven/KU Leuven
Leuven, Vlaams-Brabant, Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ML7245
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.